Wan, Yong
- Emory University · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #50,053
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$3
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#50,053
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Wan, Yong as a PI. Multi-PI records show the full award amount for context.
- 5R01CA258857-03R01Contact PITargeting posttranslational modifications of CD73 in TNBCsEmory University · Pharmacology (NIH department code)$1award amount
- 5R01CA258765-03R01Contact PITargeting posttranslational modifications of B7-H4 in carcinogenesis and therapyEmory University · Pharmacology (NIH department code)$1award amount
- 5R01CA250110-04R01Contact PITargeting Posttranslational Modifications in Breast CarcinogenesisEmory University · Pharmacology (NIH department code)$1award amount
Award organization
Organizations that administered FY2023 awards listing Wan, Yong as a PI.
FY2023 award administered by Emory University (GA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardEmory University
- 2007$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2012R01 Grant Holder
- 2013$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #9688
- 2021$5M Cumulative Funding
- 2021Entered Top 25% NationallyRanked #3716